Accumulating evidence supports the key role that CSK may play in inhibiting cancer progression by downregulating SFK oncogenic activity (Masaki et al., 1999; Nakagawa et al., 2000; Bénistant et al., 2001; Kuga et al., 2020). Here, CSK is linked to cancer.